子類別 期刊論文 [48/49] 圖書 [2/4] 會議論文/會議摘要 [16/16] 鄰近社群 何英剛(2006-2011) [38/38] 劉玉麗 [127/130] 劉誠珍 [35/35] 周文海 [11/11] 林彥鋒 [28/29] 王先逸(2005-2010) [5/5] 王昀 [59/59] 王聲昌 [55/58] 羅爾維(2004-2012) [39/39] 謝奉勳 [32/34] 陳嘉祥(2009-2013) [62/64] 陳娟瑜(2004-2010) [89/92] 陳慧諴 [48/50] 陳為堅 [46/47] 陶寶綠 [34/36] 魏榮泰(2004-2010) [2/2] 其他 [152/155] 廖定烈(2005-2008) [18/18] 林兆東(2006-2009) [8/8] 社群統計 近3年內發表的文件:0(0.00%) 含全文筆數:66(95.65%) 文件下載次數統計 下載大於0次:66(100.00%) 下載大於100次:66(100.00%) 檔案下載總次數:48298(0.90%) 最後更新時間: 2024-12-01 03:13 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Ethno-psychopharmacology: Advances ... Effects of genetic variants of ADH1... Assessment of CYP450 genetic variab... The association of genetic polymorp... Pharmacogenomics study in a Taiwane... Functional genetic polymorphisms in... Comparison of escitalopram and paro... CYP1A2 genetic polymorphisms are as... PXR polymorphisms interacted with C... OPRM1 genetic polymorphisms are ass...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 69. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2015-02	Effects of genetic variants of ADH1B and ALDH2 and social network on continued alcohol drinking among young adolescents in Taiwan	Drug and Alcohol Dependence. 2015 Feb;147:38-45.
2014-05	Assessment of CYP450 genetic variability effect on methadone dose and tolerance	Pharmacogenomics. 2014 May;15(7):977-986.
2014-04	The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance	Journal of Clinical Psychopharmacology. 2014 Apr;34(2):205-211.
2013-12	Pharmacogenomics study in a Taiwanese methadone maintenance cohort	Journal of Food and Drug Analysis. 2013 Dec;21(4 Suppl.):S62-S68.
2013-11	Comparison of escitalopram and paroxetine in the treatment of major depressive disorder	International Clinical Psychopharmacology. 2013 Nov;28(6):339-345.
2013-09	Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort	OMICS :A Journal of Integrative Biology. 2013 Sep;17(10):519-526.
2013-07	CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions	Pharmacogenomics. 2013 Jul;14(10):1191-1201.
2013-04	Psychotropic drugs and risk of motor vehicle accidents: A population-based case-control study	British Journal of Clinical Pharmacology. 2013 Apr;75(4):1125-1133.
2013-02	OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: A cross sectional study	Journal of Human Genetics. 2013 Feb;58(2):84-90.
2013-02	PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites	Journal of Clinical Psychopharmacology. 2013 Feb;33(1):137-140.
2012-10	Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients	European Neuropsychopharmacology. 2012 Oct;22(10):695-703.
2012-10	Overlapping prescriptions of stimulants for children and adolescents with attention-deficit hyperactivity disorder	Psychiatric Services. 2012 Oct;63(10):1011-1018.
2012-07	Gender differences in widowhood effects among community-dwelling elders by causes of death in Taiwan	Annals of Epidemiology. 2012 Jul;22(7):457-465.
2012-04	ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics [Erratum:Pharmacogenomics Journal. 2010 Feb;10(1): 30-39.]	Pharmacogenomics Journal. 2012 Apr;12(2):184.
2012-03	CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage	Clinical Pharmacology and Therapeutics. 2012 Mar;91(Suppl. 1):S62.
2011-10	Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients	Pharmacogenomics. 2011 Oct;12(10):1397-1406.
2011-08	CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer	Journal of Clinical Psychopharmacology. 2011 Aug;31(4):463-469.
2011-08	Depression trajectories and obesity among the elderly in Taiwan	Psychological Medicine. 2011 Aug;41(8):1665-1676.
2011-08	Five-year trajectories of long-term benzodiazepine use by adolescents: Patient, provider, and medication factors	Psychiatric Services. 2011 Aug;62(8):900-907.
2011-06	Differential effects of predictors on methylphenidate initiation and discontinuation among young people with newly diagnosed attention-deficit/hyperactivity disorder	Journal of Child and Adolescent Psychopharmacology. 2011 Jun;21(3):265-273.
2011-05	Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):71.
2011-05	The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction	Drug Metabolism Reviews. 2011 May;43(Suppl.1):26.
2011-05	Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):25-26.
2011-05	Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients	Biological Psychiatry. 2011 May;69(9 Suppl.1):229S-230S.
2011-04	ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment	Pharmacogenetics and Genomics. 2011 Apr;21(4):163-170.

顯示項目1-25 / 69. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目